123 related articles for article (PubMed ID: 3262618)
21. Glucocorticoid induction of plasminogen activator and plasminogen activator-inhibitor messenger RNA in rat hepatoma cells.
Heaton JH; Gelehrter TD
Mol Endocrinol; 1989 Feb; 3(2):349-55. PubMed ID: 2469009
[TBL] [Abstract][Full Text] [Related]
22. Plasminogen activator inhibitor 2: regulation of gene transcription during phorbol ester-mediated differentiation of U-937 human histiocytic lymphoma cells.
Schleuning WD; Medcalf RL; Hession C; Rothenbühler R; Shaw A; Kruithof EK
Mol Cell Biol; 1987 Dec; 7(12):4564-7. PubMed ID: 3325828
[TBL] [Abstract][Full Text] [Related]
23. Phorbol ester stimulates the synthesis and secretion of brain natriuretic peptide from neonatal rat ventricular cardiocytes: a comparison with the regulation of atrial natriuretic factor.
LaPointe MC; Sitkins JR
Mol Endocrinol; 1993 Oct; 7(10):1284-96. PubMed ID: 8264660
[TBL] [Abstract][Full Text] [Related]
24. Tumor necrosis factor-alpha regulates mRNA for urokinase-type plasminogen activator and type-1 plasminogen activator inhibitor in human neoplastic cell lines.
Georg B; Helseth E; Lund LR; Skandsen T; Riccio A; Danø K; Unsgaard G; Andreasen PA
Mol Cell Endocrinol; 1989 Jan; 61(1):87-96. PubMed ID: 2501120
[TBL] [Abstract][Full Text] [Related]
25. Cloning of the mink plasminogen activator inhibitor type-1 messenger RNA: an mRNA with a short half life.
Chuang TH; Hamilton RT; Nilsen-Hamilton M
Gene; 1995 Sep; 162(2):303-8. PubMed ID: 7557448
[TBL] [Abstract][Full Text] [Related]
26. Plasminogen activator inhibitor type 1: cell-specific and differentiation-induced expression and regulation in human cell lines, as determined by enzyme-linked immunosorbent assay.
Lund LR; Georg B; Nielsen LS; Mayer M; Danø K; Andreasen PA
Mol Cell Endocrinol; 1988 Nov; 60(1):43-53. PubMed ID: 3265112
[TBL] [Abstract][Full Text] [Related]
27. Disruption of microtubules inhibits the stimulation of tissue plasminogen activator expression and promotes plasminogen activator inhibitor type 1 expression in human endothelial cells.
Santell L; Marotti K; Bartfeld NS; Baynham P; Levin EG
Exp Cell Res; 1992 Aug; 201(2):358-65. PubMed ID: 1639133
[TBL] [Abstract][Full Text] [Related]
28. Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor.
Schleef RR; Bevilacqua MP; Sawdey M; Gimbrone MA; Loskutoff DJ
J Biol Chem; 1988 Apr; 263(12):5797-803. PubMed ID: 3128548
[TBL] [Abstract][Full Text] [Related]
29. Post-transcriptional regulation of plasminogen activator inhibitor type-1 expression in human pleural mesothelial cells.
Shetty S; Velusamy T; Shetty RS; Marudamuthu AS; Shetty SK; Florova G; Tucker T; Koenig K; Shetty P; Bhandary YP; Idell S
Am J Respir Cell Mol Biol; 2010 Sep; 43(3):358-67. PubMed ID: 19855086
[TBL] [Abstract][Full Text] [Related]
30. Retinoic acid potentiates phorbol ester-mediated induction of urokinase and plasminogen activator inhibitor type 2 in human myeloid leukemic cell lines.
Schuster WA; Medcalf RL; Kruithof EK
Endocrinology; 1993 Oct; 133(4):1724-30. PubMed ID: 8404615
[TBL] [Abstract][Full Text] [Related]
31. Heparin selectively inhibits synthesis of tissue type plasminogen activator and matrix deposition of plasminogen activator inhibitor 1 by human mesangial cells.
Hagège J; Delarue F; Peraldi MN; Sraer JD; Rondeau E
Lab Invest; 1994 Dec; 71(6):828-37. PubMed ID: 7807964
[TBL] [Abstract][Full Text] [Related]
32. Regulation of the expression of type 1 plasminogen activator inhibitor in Hep G2 cells by epidermal growth factor.
Lucore CL; Fujii S; Wun TC; Sobel BE; Billadello JJ
J Biol Chem; 1988 Nov; 263(31):15845-8. PubMed ID: 2846525
[TBL] [Abstract][Full Text] [Related]
33. Positive and negative regulation of a tumor necrosis factor response in melanoma cells.
Johnson SE; Baglioni C
J Biol Chem; 1990 Apr; 265(12):6642-9. PubMed ID: 2324095
[TBL] [Abstract][Full Text] [Related]
34. Down-regulation of proteolytic activity in 12-O-tetradecanoyl-phorbol-13-acetate-induced K562 leukemia cell cultures: depletion of active urokinase by excess type 1 plasminogen activator inhibitor.
Alitalo R; Andersson LC; Tapiovaara H; Sistonen L; Vaheri A; Stephens R
J Cell Physiol; 1989 Jul; 140(1):119-30. PubMed ID: 2500450
[TBL] [Abstract][Full Text] [Related]
35. Regulation of mRNAs for type-1 plasminogen activator inhibitor, fibronectin, and type I procollagen by transforming growth factor-beta. Divergent responses in lung fibroblasts and carcinoma cells.
Keski-Oja J; Raghow R; Sawdey M; Loskutoff DJ; Postlethwaite AE; Kang AH; Moses HL
J Biol Chem; 1988 Mar; 263(7):3111-5. PubMed ID: 3125175
[TBL] [Abstract][Full Text] [Related]
36. Glucocorticoid-modulated gene expression of tissue- and urinary-type plasminogen activator and plasminogen activator inhibitor 1 and 2.
Medcalf RL; Van den Berg E; Schleuning WD
J Cell Biol; 1988 Mar; 106(3):971-8. PubMed ID: 3126194
[TBL] [Abstract][Full Text] [Related]
37. Dexamethasone and phorbol ester, but not cytokines, increase the production of plasminogen activator inhibitor type-2 in the PL-21 human promyelocytic leukemia cell line.
Niiya K; Takeuchi T; Kobayashi M; Miyoshi I; Hayashi T; Sakuragawa N
Thromb Haemost; 1991 Aug; 66(2):232-8. PubMed ID: 1771617
[TBL] [Abstract][Full Text] [Related]
38. Induction and desensitization of plasminogen activator gene expression by tumor promoters.
Degen JL; Estensen RD; Nagamine Y; Reich E
J Biol Chem; 1985 Oct; 260(23):12426-33. PubMed ID: 3862668
[TBL] [Abstract][Full Text] [Related]
39. The THP-1 cell line is a urokinase-secreting mononuclear phagocyte with a novel defect in the production of plasminogen activator inhibitor-2.
Gross TJ; Sitrin RG
J Immunol; 1990 Mar; 144(5):1873-9. PubMed ID: 2307845
[TBL] [Abstract][Full Text] [Related]
40. Down-regulation of urokinase secretion from a human lymphoma cell line RC-K8 by dexamethasone without inducing plasminogen activator inhibitors.
Niiya K; Nsimba M; Hayashi T; Sakuragawa N
Thromb Res; 1992 Feb; 65(3):311-21. PubMed ID: 1631798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
